Related Experiment Video

Updated: Oct 25, 2025

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

24.4K

A Comparative Study of High-intensity Rosuvastatin Versus Atorvastatin Therapy Post-acute Coronary Syndrome Using

Alaa Rahhal1, Fadi Khir2, Bassant Orabi1

  • 1Heart Hospital, Hamad Medical Corporation, Doha, Qatar.

Current Problems in Cardiology
|August 7, 2021
PubMed

Insights

High-intensity rosuvastatin and atorvastatin show similar effectiveness and safety for preventing cardiovascular events after acute coronary syndrome (ACS). This finding supports both statins for secondary CVD prevention in ACS patients.

Area of Science:

  • Cardiology
  • Pharmacology
  • Clinical Research

Background:

  • High-intensity statins are crucial for secondary cardiovascular disease (CVD) prevention.
  • Real-world data on rosuvastatin's effectiveness post-acute coronary syndrome (ACS) is limited.
  • Atorvastatin is a commonly used high-intensity statin for ACS patients.

Purpose of the Study:

  • To compare the cardiovascular effectiveness and safety of high-intensity rosuvastatin versus atorvastatin in ACS patients.
  • To evaluate the primary composite outcome of CVD-associated death, non-fatal ACS, and non-fatal stroke.
  • To assess outcomes at 1 month and 12 months post-discharge.

Main Methods:

  • Retrospective cohort study design.
  • Inclusion of patients diagnosed with ACS.
  • Comparison of rosuvastatin and atorvastatin high-intensity statin therapies.

Main Results:

  • No significant difference in the primary composite outcome between rosuvastatin and atorvastatin at 1 month (aHR=1.64, P=0.379) and 12 months (aHR=1.48, P=0.199).
  • Effectiveness outcomes were comparable: 1.3% vs 1% at 1 month and 4.8% vs 3.5% at 12 months.
  • Safety outcomes were also comparable between the two high-intensity statin groups.

Conclusions:

  • High-intensity rosuvastatin therapy is comparable to high-intensity atorvastatin therapy in terms of cardiovascular effectiveness and safety for patients with ACS.
  • These findings provide real-world evidence supporting the use of rosuvastatin for secondary CVD prevention in ACS.
  • Both statins can be considered for managing patients post-ACS.

More Related Videos

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

3.9K

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
53
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
74
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
77
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.0K
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
168
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
94